Introduction
Germinal centers (GCs) represent critical sites within lymphoid tissues, where B cell responses to antigen are amplified and refined through the mechanism of affinity maturation (1) . Recently, key dynamic features of the GC emerged from 2-photon intravital imaging studies. Antigen-activated B cells are highly motile and move bidirectionally between the dark and light zones, indicating that repeated cycles of cell proliferation and mutation are a central event of affinity maturation (2, 3) . Activated B cells can also colonize preexisting GCs containing B cells specific to unrelated antigens, provided that T cell help is available (4, 5) . Furthermore, single clones were found to seed multiple GCs, suggesting the iterative involvement of antigen-experienced cells in GC reactions. Two recent mouse studies provided direct evidence that memory B cells promote the persistence and/or reinitiation of secondary GC reactions following antigen recall (6, 7) . Importantly, whereas switched memory B cells will rapidly undergo clonal expansion and differentiation into high-affinity plasma cells, the IgM subset reenters a GC reaction, allowing the formation of a new generation of IgM-and IgG-expressing cells and providing replenishment of the memory pool.
This property of GC reentry and memory B cell response dynamics has provided new perspectives on the understanding of the early steps governing B cell lymphomagenesis, in particular those originating from GC B cells (5) . Due to massive clonal expansion combined with the active error-prone genome-remodeling processes of receptor maturation, GC B cells are at increased risk of genomic instability and lymphomagenesis, and many B cell lymphomas have been shown to derive from the GC (8) . As a paradigm of such a process, GC entry of naive B cells with t(14;18)(q32;q21) translocation is assumed to be a key step to follicular lymphoma (FL) genesis by allowing BCL2-driven rescue from apoptosis of B cells with low-affinity receptors and accumulation of developmentally blocked GC B cells with constitutive activation-induced cytidine deaminase (AID) activity (9) . This "trapping" of activated GC B cells in the reactive follicle would be a key step to malignant progression, whereby genomic instability enhances the acquisition of complementary oncogenic hits and progressive transformation into overt FL, gradually spreading from the founder follicle to the surrounding ones in the node, then disseminating to distant It has recently been demonstrated that memory B cells can reenter and reengage germinal center (GC) reactions, opening the possibility that multi-hit lymphomagenesis gradually occurs throughout life during successive immunological challenges. Here, we investigated this scenario in follicular lymphoma (FL), an indolent GC-derived malignancy. We developed a mouse model that recapitulates the FL hallmark t(14;18) translocation, which results in constitutive activation of antiapoptotic protein B cell lymphoma 2 (BCL2) in a subset of B cells, and applied a combination of molecular and immunofluorescence approaches to track normal and t (14;18) + memory B cells in human and BCL2-overexpressing B cells in murine lymphoid tissues. BCL2-overexpressing B cells required multiple GC transits before acquiring FL-associated developmental arrest and presenting as GC B cells with constitutive activation-induced cytidine deaminase (AID) mutator activity. Moreover, multiple reentries into the GC were necessary for the progression to advanced precursor stages of FL. Together, our results demonstrate that protracted subversion of immune dynamics contributes to early dissemination and progression of t (14;18) + precursors and shapes the systemic presentation of FL patients.
Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression (such as immunization) and tracking of the clonal evolution of BCL2 + cells in otherwise healthy mice. We first used sensitive fluctuation PCR (F-PCR) assays (primers 1 + 2) to monitor BCL2 expression over time in resting BCL2 tracer mice ( Figure 1 , B and C). Similar to t (14;18) in healthy humans, we observed variable low BCL2 CJ frequencies (from <10 -6 to 5 × 10 -5 ) in blood and lymphoid organs (but not in liver or kidneys). As expected in resting conditions, BCL2
CJ frequencies monitored on sorted B cell fractions showed that most huBCL2 + cells were naive B cells ( Figure 1D , white bars). Accordingly, staining for peanut agglutinin (PNA) and huBCL2 on histological spleen sections showed limited GC formation and did not reveal the presence of spontaneous BCL2
+ FLIS-like structures, even in aged mice (Figure 1E , top panels).
We then tested the central FL hypothesis that rescue from apoptosis of activated GC B cells with enforced BCL2 expression provokes their accumulation in situ and maturation block. To drive naive B cells into the GC reaction, we performed shortterm immunization ( Figure 1F ) using sheep red blood cells (srbc), which are known to induce a large polyclonal response in mice. Alternatively, BCL2 tracer mice were bred with Lat Y136F mice, in which uncontrolled Th cell signaling provokes massive GC entry and activation of naive B cells in an antigen-independent manner (22) . Upon such activation conditions, GC and post-GC B cell subsets became apparent on IHC ( Figure 1E , bottom panels) or FACS (Supplemental Figure 2 ). Confocal microscopic analysis showed rare frequencies of transgenic huBCL2 protein expression ( Figure 1F ). However, we observed no huBCL2 + FLIS-like clusters by IHC ( Figure 1E , bottom panels) or confocal microscopy ( Figure 1F ). We thus performed F-PCR to evaluate the relative frequency of BCL2 + cells (BCL2 CJ ) in each of the purified B cell fractions following immunization ( Figure 1D , middle panel) or breeding with Lat Y136F mice ( Figure 1D , right panel). We observed no significant increase in BCL2 CJ frequencies in the GC fractions compared with that in memory or terminally differentiated plasma cells ( Figure 1D ). We conclude that during the first GC transits, BCL2 + GC B cells do not accumulate in situ, but rather differentiate into plasma or memory cells. This strongly argues against a model in which BCL2, by driving rescue from apoptosis, would provoke early differentiation arrest and GC accumulation of t (14;18) + GC B cells and eventual FLIS formation.
Chronic immunization drives preferential accumulation and reentry of activated BCL2
+ B cells into the GC. If most t(14;18) + cells transiting for the first time through the "founder GC" initially exit as genuine terminally differentiated memory B cells, how do these cells progress back to FL precursors and FL? In line with an increasing t(14;18) incidence with age and the late onset of FL, Bende et al. have proposed that lymphoma progression does not arise during the first GC passage, but may gradually develop in memory B cells during successive/episodic recall responses throughout life (5) .
We thus tested whether long-term antigenic stimulation preferentially stimulated the proliferation of BCL2 + B cells by tracking the evolution of their frequency during chronic immunization in BCL2 tracer mice (Figure 2A ). To do so, we used the Aid-Cre Rosa-EYFP mice (in which EYFP is expressed in activated B cells upon AID expression during their first passage in the GCs; ref. 23 ). BM progenitors from these mice were transduced with a retrovilymphoid organs, including BM, to eventually manifest as a systemic disease (10) hi GCs (11) . Molecular analyses have confirmed the implication of a clonal population of t (14;18) + B cells. Progression to FL has been observed in less than 5% of FLIS patients over a period ranging from a few months to several years (12) . However, the tumor does not systematically manifest at the FLIS anatomical site, indicating a dynamic GC process with dissemination of potent precursors in other tissues and blood (11) . FLLCs have been proposed as the circulating counterparts of FLIS (12) . Although present in approximately 85% of FL patients, t(14;18) is also detectable at low frequencies (~10 -6 ) in up to 70% of individuals in the normal healthy population (13) (14) (15) , indicating that ectopic BCL2 expression is necessary but not sufficient for FL development. In such individuals, most circulating t (14;18) + cells constitute an expanding clonal population of atypical blood B cells that have already transited through the GC and display a combination of illegitimate genotypic and phenotypic features of FL (developmentally blocked GC B cells and imprints of AID-mediated genomic instability) (14, 16) . High t(14;18) frequencies were also fortuitously detected in prediagnostic blood samples from healthy individuals who subsequently developed FL up to 20 years later (17, 18) and in samples from allogeneic donors who developed FL synchronously with the BM recipients (19, 20) . The long latency observed in these cases, combined with the persistence of t(14;18) clones over more than 10 years of follow-up (21) , provide further evidence that FL is preceded by an insidious preclinical phase of asymptomatic growth and might emerge from precursor clones evolving over years, if not decades.
The mechanisms governing the transition and progression from t (14;18) + B cells to early FL precursors are to date unknown. Here, we sought to address this important issue by tracking early FL precursor dynamics throughout human and mouse B cell ontogeny.
Results

A mouse model mimicking t(14;18) translocation in healthy humans.
To recapitulate the primary events leading to the generation of FLLCs and FLIS cells, we engineered a mosaic mouse model (BCL2 tracer ), in which sporadic and conditional BCL2 transgene activation aims to mimic the rare occurrence of t(14;18) in the BM. The BCL2 tracer mouse, in which the expression of a functional human BCL2 (huBCL2) transgene is contingent on its inversion by V(D)J recombination, recreates the sporadic occurrence of the t(14;18) translocation event in humans (~10 -6 ), induced at the appropriate developmental stage (BM pro-/pre-B cells), and generates a unique coding joint (referred to herein as BCL2 CJ ) substituting the human t(14;18) translocation between BCL2 and the Ig heavy chain junction region (BCL2/J H ) as a clonotypic marker ( Figure 1A and Supplemental Figure 1 ; supplemental material available online with this article; doi:10.1172/JCI72415DS1). In this sporadic model, the preservation of normal B cell populations (Supplemental Figure 2) allows the evaluation of selective modifications of the initial BCL2 CJ frequency following perturbations tracer mice stained with B220 (pan-B), PNA (GC marker), and huBCL2 antibodies. A human spleen was used as a positive control for huBCL2 staining. PNA was used instead of GL7 (44) Figure 3A ) and GL7
-post-GC fractions ( Figure 3D ), demonstrating that differentiated post-GC huBCL2 + memory B cells can rapidly return to the GC upon antigenic recall. To further study the role of IgM expression in the reentry process, we independently transferred GL7 + IgM + and GL7 + IgG + fractions purified from BCL2 tracer -transduced mice. Interestingly, huBCL2 + IgG + B cells showed mostly an extrafollicular localization in the red pulp of the spleen, suggesting that they did not return to the GCs after stimulation, or at least not to the same extent as did huBCL2 + IgM + cells (Supplemental Figure  3B) . The return to the GC of BCL2
+ cells thus appears to be highly dependent on the expression of IgM on the cell surface.
Is this GC reentry able to drive a new round of GC reactions? In a series of consecutive sections from recipient mice, we observed the tight clustering of huBCL2 + B cells in a single GC surrounded by negative ones ( Figure 3E and Supplemental Figure 3 , A and B). This suggested the entry of a single huBCL2 + B cell, followed by in situ clonal proliferation, histologically mimicking a human FLIS cell ( Figure 3E ). Total cells from 1 section were scraped off the slide, DNA extracted, and BCL2 CJ+ monitored. We observed a drastic increase in BCL2 CJ frequencies and a reduction of clonality (1 dominant clone was amplified in 100% of the F-PCR lanes; Figure 3F and Supplemental Table 1 ), in line with the clonal features of FLIS. Notably, this clone was also dominant in the other recipient mouse from the same donor ( Figure 3B ), suggesting that it acquired enhanced capabilities to colonize GCs and reactivate GC reactions. VH gene analysis confirmed the emergence of progressive clonal restriction in some GCs before adoptive transfer, along with the occurrence of intraclonal variation (ICV) due to ongoing AID activity (Supplemental Table 2 ).
Recent genomic studies have shown that human FLIS samples have already acquired additional alterations in addition to t(14;18) (24, 25) . We thus investigated whether the enhanced capacity of BCL2 + cells to undergo iterative GC reactions in chronically challenged BCL2 tracer mice is accompanied by an accumulation of genomic instability and potentially mimics genetic features of human early FL entities. We performed exome sequencing on purified BCL2-enriched GC and memory cell fractions from 3 chronically immunized (BCL2-transduced) mice and 1 control (empty vector) mouse (Supplemental Table 3 ). BCL2-low (≤1%) naive fractions from the corresponding mice were also sequenced and used as a germline reference. Due to the low DNA content per subset, we performed whole-genome amplification (WGA) before sequencing. The 50-Mb exome capture was sequenced to a mean depth of 172X across all mice (range = 118X-214X; Supplemental Table 3 ). We used a stringent bioinformatic filtering pipeline to remove known genetic and recurrent false-positive variants (Supplemental Figure 4 ). Overall, from an initial set of several thousands of raw variant calls, the cumulative filtering of and focusing on protein-altering changes identified between 111 and 2,565 nonsilent (nonsynonymous, stop gain, or stop loss) single nucleotide variants (SNVs) per B cell subset in the BCL2-transduced mice compared with 63 to 70 SNVs in the control mouse ( Figure 4A and Supplemental Table 4 ). In all BCL2 tracer -transduced mice, the rus-based BCL2 tracer construct, keeping the sporadic occurrence of BCL2 inversion (driven by recombination-activating genes [RAGs] in the BM). To mimic chronic antigenic recall, we immunized chimeras with srbc every 20 days for 9 months (starting on day 45). Upon sacrifice, no significant splenomegaly was manifest. Nevertheless, chronically immunized huBCL2-transduced mice showed a significant increase in GC and memory B cells compared with that seen in controls (WT/empty vector) ( Figure 2B ). We then measured the distribution of huBCL2 + cells among the total population of EYFP + activated B cells. Strikingly, we observed a massive accumulation of huBCL2 + cells in GC and memory B cell compartments (up to 90%), but not in naive B cells (Figure 2 , C-F) or in unstimulated conditions ( Figure 2D ). Importantly, in both compartments, BCL2 + cells remained predominantly IgM + (60% of cells) ( Figure 2G ). This indicates that upon repeated antigenic challenges, constitutive BCL2 expression in GC and memory B cells confers a considerable selective advantage over their BCL2 -counterparts, in line with an enhanced GC reentry. Notably, this subtle widespread expansion and GC colonization by huBCL2 + B cells in the absence of macroscopic tissue distortion is in line with the early, nonmalignant phases of indolent lymphomagenesis in human FLIS, which can progress to overt disease with low frequencies (~5%) and long latencies (several years or decades) (12) .
To formally assess whether these huBCL2 + B cell expansions occurred through cycles of GC exit and reentry and repeated rounds of GC reaction, we took advantage of EYFP labeling. EYFP + splenic GC or post-GC B cells from 4 chronically immunized mice were cell sorted and adoptively transferred (~20,000-50,000 cells/transfer) into WT mice (preimmunized and reboosted once with srbc) ( Figure 3A ). Mice were sacrificed 1 week later, and BCL2 CJ was monitored in total and cell-sorted spleens. Remarkably, despite the very low quantity of transferred cells and the short time allowed after transfer, BCL2
CJ could be observed in the spleen ( Figure 3B ) and was enriched in activated B cell fractions from recipient mice ( Figure 3C ). We found identical clones in recipient mice that received the GC or post-GC fraction, showing GC fractions exhibited an increased frequency of SNVs relative to those in matched IgM or switched memory cell fractions. We found most of the detected SNVs at low variant allelic frequencies (VAFs) (5%-25%), while a limited set of gene mutations presented at higher frequencies (>30%) and were present in the distinct fractions of a given mouse ( Figure 4B and Supplemental Table 5 ). Finally, G→A and C→T transitions were the most common nucleotide substitutions, consistent with AID-mediated activity ( Figure  4C ). Altogether, this suggests that huBCL2 + B cells accumulating in GCs upon chronic immunizations collected additional mutations at a significantly higher rate than did their BCL2 -and peripheral counterparts (normal GC and memory B cells). Importantly, the large number of mutations at low VAFs parallels the situation in human FLIS, in which recurrent FL hits are rarely observed (24, 25) . In both cases, human FLIS and murine FLIS-like cells thus seemingly stand at a crossroads between increased genomic instability and low selective pressure for malignant transformation (24) , consistent with their low rate of progression to overt FL (12) .
We conclude that chronic immunization favored dissemination of BCL2 + B cells, iterative GC reentry, preferential clonal expansion, and eventual progression into structures resembling human FLIS, the earliest known precursor of FL development.
FL-like clones expand and disseminate extensively in human blood and tissues. To validate and extend our observations in humans, we reasoned that the more t (14;18) + cells undergo rounds of GC exit and reentry during a lifetime, the more they should expand, disseminate to various distant lymphoid organs, independently accumulate imprints of AID activity (somatic hypermutation [SHM] and class switch recombination [CSR]), and clonally diverge during clonal expansion.
The extent of dissemination was first examined in paired lymphoid tissue samples (spleen, LN, BM) and blood from a large cohort of healthy organ donors, defined here as individuals devoid of manifest hematological conditions (Supplemental Table 6 ). We performed semiquantitative F-PCR to evaluate the presence of t(14;18) and estimate t(14;18) + cell frequencies in paired blood and lymphoid tissue. This assay allowed us to detect BCL2/J H translocation with a sensitivity of 1 positive cell per 500,000 normal lymphocytes. Remarkably, this analysis revealed that a large fraction of the t(14;18) + cell pool is actually homing to tissues (Figure 5A) . We found that t (14;18) + B cells displayed a wide range of cell frequencies in most adult lymphoid tissues from most individuals ( Figure 5B ), including in the BM, where positivity correlated well with blood ( Figure 5C ), as previously observed in FL (18, 26) . BCL2/J H breakpoint analysis (Supplemental Table 7 , A-C) showed that t(14;18) cell frequencies systematically resulted from the expansion of 1 dominant clone ( Figure 6A ), disseminated in most paired tissues analyzed, with good correspondence of clonal distribution between blood and tissues ( Figure 6B ).
Molecular analysis of Sμ/Sγ regions on the translocated alleles of resident t (14;18) + B cells showed the occurrence of SHM and/ or CSR in more than 98% of cases, consistent with their status as Figure 7C ). Altogether, this suggests that t(14;18) + clones homing to tissues are an atypical "GC-like" clonal B cell population that extensively disseminated in "healthy" individuals, long before malignant transformation.
The subversion of t(14;18) + memory B cell dynamics drives sustained AID mutator activity. We next monitored clonal divergence.
A clone is made of many single daughter cells (subclones) that are potentially disseminated in remote tissues. In the presence of AID, SHM and CSR independently accumulate in each subclone, and this ICV can be used to track their genealogical history during clonal expansion ( Figure 8A) . If the global pool of t(14;18) + cells results from protracted GC coopting over many years, subclones should display more ICV than do normal memory B cells in the GC-derived B cells (Supplemental Table 8 ). Accordingly, t(14;18) was rarely detected in the sorted naive B cell subset ( Figure 6C and Supplemental Table 9 ). Within the memory B cell subset, t(14;18) was predominantly observed in the IgD/M memory B cell fraction. This "allelic paradox" (expression of surface IgD/M in a cell with a switched translocated allele) is unusual in normal memory B cells but stands as a hallmark of FL and circulating FLLCs, presumably as the result of strong selection pressure to signal through IgM (9). We next used discriminant markers to visualize and further characterize these cells by confocal analysis using BCL2 and BCL6 expression, which is normally mutually exclusive in B cells (27 ing from the trees than is apparent. The considerable clonal divergence of branched subclones largely disseminated in distant tissues concurs with a dynamic model in which iterative rounds of GC reactions occur over prolonged periods. Interestingly, we also observed such clonal divergence in t(14;18) + subclones from the paired LN and blood samples of an FLIS case, suggesting similar molecular dynamics for both precursor entities.
To comparatively track the dynamics of normal memory B cells, we attempted a similar F-LRPCR strategy, substituting the BCL2 primers with V H primers (V H 6 family, V H 3-23) (Supplemental Figure 6B) . However, and in contrast to BCL2/Sμ/Sγ, we repeatedly failed to amplify the VH/Sγ clones twice in the spleen, indicating a substantially lower clonal expansion of normal versus t(14;18) + memory B cell clones. To still gain comparative information on the dynamics of normal memory B cells, we increased same individual. To test this hypothesis, we tracked t(14;18) + subclones as single cells in paired distant tissues (spleen, LNs, or BM) and blood using fluctuation long-range PCR (F-LRPCR). LRPCR (~3-7 kb; Supplemental Figure 6A ) was required to encompass on the same amplicon both the BCL2/J H junction (the clonotypic root) and the Sμ/Sγ intronic region in which CSR and SHM accumulate (28) . Genealogical trees were then built using the BCL2/J H junction as the tree root and SHM-and CSR-based ICV to branch the subclones. Remarkably, out of 6 genealogical trees generated from 45 sequenced amplicons, we found all subclones to be distinct ( Figure 8B) . Furthermore, the distant branching of clonal variants disseminated in remote organs (e.g., donor 11) and the fairly large number of mutations between the closest neighbors (especially when belonging to distinct compartments) indicated that many more intermediate subclones and branching are miss- Table 9 for raw data). Cμ, constant mu region; Cγ, constant γ region; Sμ, switch mu region; Sγ, switch γ region. jci. 
Discussion
It has long been inferred that reactivation of immunological memory during antigenic recall involves iterative cycles of GC reentry. Nevertheless, the formal demonstration that reactivated memory B cells indeed have the plasticity to "dedifferentiate" back into centroblasts and centrocytes and re-engage in the process of mutation and selection has been only recently achieved in mice, thereby revealing the highly open dynamics of the GC structure as well as the important functional differences between memory subtypes. A similar process seems to occur in humans, although with the caveat that this involves unknown, complex, and heterogeneous immunological histories. Using a single-cell DNA-based tracking approach, we further show here that following GC exit, human memory B cell clones disseminate not only in the blood and spleen, but also in distant lymphoid organs. Interestingly, amplification efficiency by reducing the size of the amplicon (29) . We identified complementarity-determining region 3 (CDR3) junctions in sorted splenic memory B cell fractions and backtracked single B cell clones using a CDR3-specific reverse primer (Supplemental Figure 6B and Supplemental Table 10 ). Although frequencies of backtracked clones constantly remained in the low range of ~10 -5 [while up to 1,000 times more t(14;18) + clones could be found in the same organs of the same individuals] (Supplemental Table 7A ), we obtained amplicons through repeated F-PCRs and built genealogical trees based on ICV in the V H region. We seldom observed ICV, as a large amount of subclones in a given tree (up to 7) displayed strictly identical mutation patterns and/or no branching ( Figure 8C ), in line with a more limited history of GC coopting than that of t(14;18) + clones. Accordingly, the global SHM load in the Sμ/γ region was significantly lower in normal IgM + CD27
+ and switched memory B cells than in t (14;18) + cells ( Figure 8D ). Sustained and deregulated AID expression has been shown to be associated with lymphoma progression. A significantly higher rate of SHM and the occurrence of aberrant CSR events ( Figure  8 , B and E, and Supplemental Table 8 occasional high t(14;18) frequencies we observed in nonreactive tissues ( Figure 7 and Supplemental Figure 7 ) suggest that resident FLLCs represent the nonreactive counterparts of FLIS, prone to (re-)colonize GCs upon appropriate immune challenge, as seen in human reactive LNs, where they accumulated in a nonproliferative GC compartment (38) . Consistent with this hypothesis, we found clonal divergence between paired blood and LN subclones in a patient with an FLIS and in follow-up studies of t(14;18) + cells persisting in healthy individuals' blood for over 10 years (21) . This pretumoral pattern of clonal evolution is highly reminiscent of the evolutionary process governing FL transformation (39, 40) , suggesting a common and early-acquired dynamics. In this respect, our finding of highly mutated FLLCs in the BM is of particular significance. While not a homing niche for memory B cells, the BM is a frequent invasion site in FL, and it could represent an early niche for cancer stem cells (41) , in line with reported cases of synchronous FL development in donor/recipient pairs after allogeneic BM transplantation (BMT) (19, 20) . Importantly, the detection of t (14;18) + precursor FL clones in prediagnostic blood samples several years before diagnosis (17, 18, 20) supports a scenario in which some FL precursors have already acquired the defining events necessary for clonal maintenance and ineluctable malignant progression, long before symptomatic FL manifestation.
Methods
Human samples. Human samples were obtained from Hôpital de la Conception (Marseilles, France) (encephalic-death, heart-beating organ donors) and the Centre Hospitalier Universitaire (CHU) Pontchaillou (Rennes, France) (cardiac surgeries, child routine tonsillectomy, benign hyperplasia surgery) (Supplemental Table 6 ). FLIS samples, including one coupled to blood, were obtained from the hematopathology department of the Centre Henri Becquerel (Rouen, France) and the Institut Paoli Calmettes (Marseilles, France). All fresh samples were placed on ice immediately after surgical removal. Mononuclear cells were isolated by mincing tissues in RPMI containing 10% FCS followed by Ficoll density centrifugation.
Generation of sporadic BCL2 tracer transgenic mice. An inactive BCL-2 tracer transgene (5.8 kb) was cloned into the pcDNA3.1(+) vector under the control of the constitutive CMV promoter, flanked in 3′ by the IGH intronic enhancer (Eμ) and bordered by 2 chicken β-globin HS4 insulators (I) aimed to restrict the influence of the insertion sites (ref. 42 and Supplemental Figure 1A ). huBCL2 sequences were used in order to discriminate the transgenic BCL2 protein from endogenous Bcl2 in transgenic mice. The genomic sequences of huBCL2 exon 2 (containing the start codon) and exon 3 (containing the stop codon), each including part of the intronic sequences comprising the splice sites, were separately cloned in the construct in direct and inverse orientation, respectively. BCL2 exon 3 was flanked in 3′ by an IRES-H2BGFP fusion gene (43), followed by a polyA sequence, both also cloned in inverse orientation. For the generation of BCL2 tracer transgenic mice, the choice of the D H 3/J H 6 RSS pair (RSS lo ) over the other combination (RSS hi ) was motivated by its relative low efficiency in ex vivo recombination assays (Supplemental Figure 1B) , in order to mimic the low frequency of t(14;18) in humans. The functionality and oncogenic potential of the huBCL2 oncoprotein expressed from the transgenic construct was validated ex vivo (Supplemental Figure 1, C and D) and in vivo (Supplemental Figure 1E) (34) , which might be less restrictive of cross-reactivity and/or bystander activation than are most highly selected memory B cells. Third, most t (14;18) + and FL cells are selectively spared from switching isotypes at the expressed allele, despite active CSR and SHM, and thus express IgM -the so-called allelic paradox -that seemingly renders these cells more prone to GC reentry (9) . This process would, however, require time: in the mouse, we show that prolonged or chronic immunization is necessary to incite iterative GC reentry of BCL2 + B cells, preferential clonal expansion, accumulation of genomic instability, and eventual progression into histological structures resembling human in situ FL development. In humans, it may take a lifetime to recapitulate this pretumoral phase, in line with the increased incidence of FL with age and the indolent clinical course generally observed. This further supports the evidence that FL is preceded by a similar asymptomatic preclinical phase or subclinical disease, which may last for very long periods (up to 20 years before diagnosis) (18, 35) .
From an oncogenic standpoint, such frequent visits to GCs of t (14;18) + memory B cells are great incentives for genomic instability, accumulation of genomic alterations, and lymphoma progression. The inappropriate arrest of maturation is one of the characteristic deregulated functions paving the way for transformation into cancer cells (36) . This differentiation block typically occurs in FL, which classically displays a GC-like B cell phenotype (10, 37) . This block seems to already be present in FLLCs (9), and we show here that these atypical t (14;18) + cells had already colonized lymphoid organs in a large proportion of healthy individuals. How and when did recirculating t (14;18) + memory B cells acquire this developmental arrest and progress into FLLCs? It has long been assumed that t(14;18)-driven ectopic expression of BCL2 plays a critical role in this process by allowing the rescue of centrocytes with compromised survival due to low BCR affinity. We show that mere BCL2 expression in GC B cells is actually insufficient to fix such structures. Table 11 .
Whole-exome mouse sequencing and analysis. The 50-Mb mouse exome was captured using Agilent SureSelect XT, genome version GRCm38/mm10. Capture libraries were constructed from 1 μg of WGA-amplified DNA from GC and post-GC subsets (BCL2-enriched or control empty vector) and germlines (naive) using the REPLI-g Single Cell Kit (QIAGEN). Enriched exome libraries were multiplexed and sequenced on the Illumina HiSeq 2000 platform to generate 100-bp paired-end reads. All sequence data were quality controlled for read counts, quality values, kmer usage, GC content, and all other relevant parameters within FastQC version 0.10.1 (Babraham Bioinformatics). The DNA sequence was aligned to the mouse genome (UCSC mm10; Dec 2011 release; Genome Reference Consortium GRCh38) using Bowtie2, version 2.1.0 (SourceForge). SAMtools version 0.1.18 mpileup was used (Qphred >30 and mapping quality >30) with VarScan2 version 2.3.2 to call SNVs relative to the mouse reference with the following parameters: variant minimum frequency greater than 5%, VarScan2 P value for variant calls (based on Fisher's exact test) less than 0.01, minimum coverage = 20, minimum reads = 3, minimum average quality = 30, and minimum frequency for homozygote = 0.8.
Variant calls were made for all samples in a batch call and exported as a Variant Call Format (VCF) version 4.1 (1000 Genomes) file. Then, variant call refinement was conducted according to the following rules for somatic SNV calls between pairs of GC versus naive fractions and IgMmem versus naive fractions: (a) average Qphred score for reference or variant (or both) greater than 30 for whole-exome sequencing (WES) in naive, GC, and IgMmem fractions; (b) P value by Fisher's exact test of less than 0.01 for read counts between naive, GC, or IgMmem fractions and reference or variant; (c) VAF in naive fractions of less than 3%; and (d) GC or IgMmem VAF at least 5% greater than the VAF of the naive fraction. Annotation and variant effects on genes were then conducted using ANNOVAR (version 2013-07-28), and all nonsilent (i.e., nonsynonymous, stopgain, or stoploss) SNVs were selected. Putative somatic variants identified in dbSNP (snp138) were removed from consider- in RPMI containing 10% FCS, 10 ng/ml mIL-7, 10 ng/ml mFlt3-L, and 100 ng/ml mSCF (Peprotech). Retroviral supernatants were mixed with polybrene (4 μg/ml), and viruses were transduced into BM progenitors by spinoculation at 1,800 g for 2 hours at 33°C on 2 consecutive days, and 1 × 10 5 to 5 × 10 5 transduced BM cells were injected via the retro-orbital plexus in lethally irradiated C57BL/6 mice. All mice were monitored daily for evidence of disease, sacrificed, and autopsied upon manifest signs of disease (lethargy, organomegaly).
Immunization protocols and adoptive transfer experiments. For short-term immunizations, 8-to 12-week-old mice were immunized by i.p injection of srbc (1 × 10 9 ), boosted twice (day 15 and day 30), and tissues were analyzed 7 days after the last immunization by cell sorting, molecular analysis, and histology.
For long-term chronic immunizations, mice were immunized by i.p. injection of srbc (1 × 10 9 ) followed by sequential injections of srbc every 3 weeks over a 9-month period ( Figure 2 ). Mice were sacrificed on day 7 after the last injection at the peak of the GC response, and tissues were processed for flow cytometry, cell sorting, and molecular analysis. 
